| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/02/2009 | CA2503900C Purine compounds and use thereof as cannabinoid receptor ligands |
| 06/02/2009 | CA2394606C New modulators of dopamine neurotransmission |
| 06/02/2009 | CA2392025C Process for the preparation of amorphous atorvastatin |
| 06/02/2009 | CA2377230C Benzimidazole compounds and medicaments comprising the same |
| 06/02/2009 | CA2362594C Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate |
| 06/02/2009 | CA2350425C Use of an insulin sensitiser for the treatment of type 2 diabetes mellitus |
| 06/02/2009 | CA2344290C Quinazoline derivatives |
| 06/02/2009 | CA2340416C Co-lyophilized complex of a nucleic acid vector and a formulating agent |
| 06/02/2009 | CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof |
| 05/28/2009 | WO2009067268A1 Methods of enhancing diabetes resolution |
| 05/28/2009 | WO2009067182A2 Phospholipid compositions and uses thereof |
| 05/28/2009 | WO2009066681A1 Lactic acid bacterium-containing preparation |
| 05/28/2009 | WO2009066298A1 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof |
| 05/28/2009 | WO2009066021A1 Use of oleocanthal for the treatment of lipid metabolism disorders |
| 05/28/2009 | WO2009065845A1 A method for treating over-eating disorders |
| 05/28/2009 | WO2009065298A1 Piperazine derivatives, preparation process and pharmaceutical use thereof |
| 05/28/2009 | WO2009065287A1 Novel mangiferin calcium salts, the method for its preparation and its use |
| 05/28/2009 | WO2009048959A8 Rapid acting injectable insulin compositions |
| 05/28/2009 | WO2009046880A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009046858A3 Therapeutic uses of kisspeptin 13 and compositions thereof |
| 05/28/2009 | WO2009046822A3 Use of the peptide ymdgtmsqv as a therapeutic agent |
| 05/28/2009 | WO2009045313A3 Oxypiperidine derivatives as histamine receptor antagonists |
| 05/28/2009 | WO2009043527A3 Therapeutic use of human growth hormone 1-43 |
| 05/28/2009 | WO2009043521A3 Use of urocortin iii and urocortin i as therapeutic agents |
| 05/28/2009 | WO2009043506A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009043456A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009040051A3 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent |
| 05/28/2009 | WO2009040005A3 Use of the peptide rfmwmr as a therapeutic agent |
| 05/28/2009 | WO2009039985A3 Therapeutic uses of urocortin ii |
| 05/28/2009 | WO2009039984A3 Therapeutic uses of urocortin ii and kisspeptin ( 27-54 ) |
| 05/28/2009 | WO2009039983A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009039978A3 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof |
| 05/28/2009 | WO2009033747A3 Use of a peptide as a therapeutic agent |
| 05/28/2009 | WO2009033660A3 Use of octreotide as a therapeutic agent |
| 05/28/2009 | WO2009026657A8 Flavonoid ppar agonists |
| 05/28/2009 | WO2009013010A3 5ht6-ligands such as sulfonamide derivatives in drug- induced weight-gain |
| 05/28/2009 | WO2009010968A3 Disease treatment via antimicrobial peptides or their inhibitors |
| 05/28/2009 | WO2008051977A8 Methods of reducing phosphate absorption |
| 05/28/2009 | US20090138978 Use of bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137673 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137671 Methods of treating metabolic disorders |
| 05/28/2009 | US20090137655 Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions and Uses Thereof |
| 05/28/2009 | US20090137631 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 05/28/2009 | US20090137626 Pharmaceutical Composition Containing PPARgamma Agonist |
| 05/28/2009 | US20090137623 Muscarinic receptor antagonists |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137599 Methods of identifying responders to dopamine agonist therapy |
| 05/28/2009 | US20090137598 Method of treating metabolic disorders and depression with dopamine receptor agonists |
| 05/28/2009 | US20090137591 Compounds and compositions as ppar modulators |
| 05/28/2009 | US20090137587 4-[(4-Chlorobenzyl)oxy]-1-(4-[(1E)-3-(methylamino)-1-propen-1-yl]phenyl)pyridin-2(1H)-one; remedy for metabolic disorders such as obesity, diabetes, hormone disorder; cardiovascular disorders (stenocardia, acute or congestive heart failure); nervous system disorders (bulimia, anxiety, epilepsy etc.) |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137574 Combination Therapy Using an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders |
| 05/28/2009 | US20090137560 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 05/28/2009 | US20090137554 1,4,5,6-TETRAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/28/2009 | US20090137551 Substituted Bicyclolactam Compounds |
| 05/28/2009 | US20090137542 Alpha-glucosidase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones |
| 05/28/2009 | US20090137536 Method for treating and preventing hyperparathyroidism |
| 05/28/2009 | US20090137530 Amine Compound and Use Thereof for Medical Purposes |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137455 Rapid acting and long acting insulin combination formulations |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136588 Methods For Altering Food Intake, Modifying Nutrient Digestibility and Altering Stool Quality and/or Stool Frequency |
| 05/28/2009 | US20090136539 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 05/28/2009 | US20090136507 HBM variants that modulate bone mass and lipid levels |
| 05/28/2009 | US20090136472 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 05/28/2009 | CA2705599A1 New compounds |
| 05/28/2009 | CA2705530A1 Phospholipid compositions and uses thereof |
| 05/28/2009 | CA2705405A1 New compounds |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062895A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2062883A1 Insulin sensitivity improving agent |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062878A1 Hydrazine amide derivative |
| 05/27/2009 | EP2062598A1 Gel type enteric nutrient |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2062587A1 Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
| 05/27/2009 | EP2062584A1 Adhesive preparation |
| 05/27/2009 | EP2061796A2 Azetidine and azetidinone derivatives useful in treating pain and disorders of lipid metabolism |
| 05/27/2009 | EP2061794A2 2-phenoxy pyrimidinone analogues |
| 05/27/2009 | EP2061792A2 Azetidinone derivatives for the treatment of disorders of the lipid metabolism |
| 05/27/2009 | EP2061791A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism |
| 05/27/2009 | EP2061786A2 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 05/27/2009 | EP2061766A2 Novel compounds |
| 05/27/2009 | EP2061483A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 05/27/2009 | EP2061479A2 Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof |
| 05/27/2009 | EP2061462A2 Treating pain, diabetes and lipid metabolism disorders |
| 05/27/2009 | EP1912946B1 Pyridine derivatives as dipeptedyl peptidase inhibitors |
| 05/27/2009 | EP1912706A4 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
| 05/27/2009 | EP1866286B1 Pyridine derivatives useful as inhibitors of pkc-theta |
| 05/27/2009 | EP1749002B1 Pyrrole or imidazole amides for treating obesity |
| 05/27/2009 | EP1742923B1 Pyrazole phenyl derivatives as ppar activators |
| 05/27/2009 | EP1615925B1 Imidazopyridine derivatives as melanocortin receptor agonists |